REAP Financial Group’s DexCom DXCM Stock Holding History

REAP Financial Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-31	Closed	-$2.41K	–	584
2024 Q4	$2.41K	Hold	31	–	–	﹤0.01%	494
2024 Q3	$2.08K	Buy	+31	New	+$2.55K	﹤0.01%	517

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

REAP Financial Group's DXCM Position: Q1 2025 in Review

REAP Financial Group sold out of DexCom (DXCM) in Q1 2025, closing a stake of 31 shares — an estimated $2.41K sold.

REAP Financial Group first reported a position in DXCM in Q3 2024 and held it in 2 quarters. The position peaked at $2.41K in Q4 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

REAP Financial Group reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
REAP Financial Group sold 31 DexCom shares in Q1 2025, an estimated $2.41K.
REAP Financial Group first reported a position in DexCom in Q3 2024 and held it in 2 quarters.
REAP Financial Group's DexCom position peaked at $2.41K in Q4 2024.
932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on REAP Financial Group's 13F filing for Q1 2025, filed 14 May 2025.